News

Stop TB Partnership: TB Research Survey


13 Dec 2010
by Working Group

ELIMINATING TB BY 2050: AN ACCELERATED GLOBAL RESEARCH STRATEGY

PLEASE PARTICIPATE TO HELP TB RESEARCH MOVING FORWARD

As a member of the large TB community, you might well be aware of the fact that research is essential for speeding up progress towards Tuberculosis (TB) elimination by 2050. We need to ensure that key research needs are being addressed, opportunities identified and prioritized, and knowledge gaps filled. Research topics differ widely in their immediate and future importance for improved TB control, but all contribute to the spectrum of research that needs to be vigorously stimulated. Therefore, the Research Movement of the Stop TB Partnership proposes to consult a wide range of stakeholders in an open web-based consultation aiming to identify the top priorities in TB research.

This consultation is open to the global TB related community and all participants are encouraged to provide feedback on the relevance of the TB research and to comment on the research topics that are of highest priority.

Please spare some time to take the survey on http://www.stoptb.org/global/research/s1/

We need your help and support in bringing TB research forward to achieve the goal of TB elimination by 2050!

TB Research Movement

The Stop TB Partnership Secretariat

World Health Organization

HTM/STB/TBP

20, avenue Appia

CH-1211 Geneva 27

Switzerland

More News
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...